Alkermes’ Corporate Presentation to Be Webcast at the Goldman Sachs 37th Annual
Global Healthcare Conference
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Goldman
Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, 2016, at 1:20 p.m. PDT (4:20 p.m. EDT/9:20 p.m.
BST) from the Terranea Resort in Rancho Palos Verdes, Calif. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of
central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical
pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis.
Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’
website at www.alkermes.com.
Alkermes
Corporate Communications
Sandra Coombs, +1 781-609-6377
View source version on businesswire.com: http://www.businesswire.com/news/home/20160601006752/en/